Exubera Inhaled Insulin in Patients with Type 1 and Type 2 Diabetes: The First 12 Months-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exubera Inhaled Insulin in Patients with Type 1 and Type 2 Diabetes: The First 12 Months

Published:2009-07 Issue:7 Volume:11 Page:427-430
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Alabraba Victoria¹,Farnsworth Adele¹,Leigh Rebecca²,Dodson Paul¹²,Gough Stephen C.L.¹³,Smyth Theresa¹

Affiliation:

1. Diabetes Centre, Selly Oak Hospital, University Hospital Birmingham NHS Foundation Trust, University of Birmingham, Birmingham, United Kingdom.

2. Diabetes Centre, Heart of England NHS Foundation Trust, University of Birmingham, Birmingham, United Kingdom.

3. Division of Medical Sciences, University of Birmingham, Birmingham, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.liebertpub.com/doi/pdf/10.1089/dia.2008.0131

Reference14 articles.

1. Resistance to Insulin Therapy Among Patients and Providers

2. Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK

3. Patient Satisfaction and Glycemic Control After 1 Year With Inhaled Insulin (Exubera) in Patients With Type 1 or Type 2 Diabetes

4. Availability of Inhaled Insulin Promotes Greater Perceived Acceptance of Insulin Therapy in Patients With Type 2 Diabetes

5. The UKPDS and its global impact

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 100 años de la comercialización de la insulina. Una carrera aún por terminar;Medicina Clínica;2023-03

2. 100 years of the commercialization of insulin: A race yet to end;Medicina Clínica (English Edition);2023-03

3. Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases;Journal of the Indian Institute of Science;2023-01

4. Insulin Delivery: An Evolution in the Technology;The Diabetes Textbook;2023

5. Discovery of insulin 100 years on;Postgraduate Medical Journal;2022-05-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3